A practice manager is always on the go – but for those moments when you do get some time to pop in some headphones Practice Business has compiled a list of some podcast suggestions you could listen to
Join Dr Sara MacDermott and Dr Lisa Adams, two GPs in the Greater Manchester area, on the Primary Care Knowledge Boost podcast as they interview specialists from different subject areas with the aim of improving the confidence and knowledge of local primary care clinicians.
Life in primary care can be complex. Deep Breath In explores the highs and lows of being a GP, offering a space to reflect on the grey areas of general practice.
This brief introduction to population health for PCNs comes from Dr Kathrin Thomas, a GP and consultant in public health. The discussion includes a clear explanation of what a population health approach means, how it can address health inequalities and improve the health of your PCN population, and some practical suggestions as to how this might be achieved.
Dr Tim Williams GP, coach and author, discusses the value of coaching for leadership development for individual PCN leaders, teams and the whole organisation.
Dr Nicky Turner, GP in Buckinghamshire and clinical director for the Chalfonts PCN, reflects on her personal leadership journey, discussing some of the opportunities and challenges facing all clinical directors. This podcast was recorded prior to the COVID-19 pandemic.
Dr Ollie Hart, GP, PCN clinical director, clinical commissioning lead for person-centred care at Sheffield CCG and passionate exponent of personalised care discusses the benefits for individual patients, health professionals and the whole system.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
1. Seqirus Data on File, August 2023. SREF–17994. 2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics. 3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics.
Be the first to comment